Subscribe

MTI Ltd. (9438.T)

JPY610.00 +2.00 (+0.33%)
JP JPX Healthcare Medical - Healthcare Information Services
Address Tokyo Opera City Tower 163-1435
Tokyo, JP
CEO Toshihiro Maeta
Website mti.co.jp
IPO 2000-01-04
ISIN JP3167480007

Explore sections of this company profile

Description

Established in Tokyo, Japan, in 1996, MTI Ltd. is a prominent provider of mobile content solutions across the nation. The company delivers a diverse portfolio of digital services designed for various user needs. These include Boshimo, an application for managing childcare records; Luna-Luna, a dedicated women's healthcare information platform; and Atleta, a system facilitating condition tracking for athletes and coaches. MTI also offers CARADA, a physical data management app that connects consumers with a network of companies, pharmacies, health examination facilities, and insurance providers. Beyond health and wellness, their services extend to financial technology with &Pay, a smartphone-based payment and transfer solution. For enterprise clients, MTI provides MOBILE CONVERT, which optimizes PC websites for mobile devices, and AMY, an artificial intelligence tool aimed at reducing operational burdens. Furthermore, their entertainment offerings encompass music.jp, a comprehensive online store for music, films, TV series, animations, books, and comics. They also operate Life Ranger, an integrated lifestyle information service featuring weather, maps, public transport connections, and navigation, alongside other general entertainment platforms.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY610.00 +2.00 (+0.33%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
40.2K
Beta
0.12
Float Shares
8.16M
Free Float %
14.7%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.17% +2.54% -1.14% -11.68% -25.40% -15.38% -27.28% +2.54% -11.68% -20.29% -96.03%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
610.00
DCF (Unlevered) 1,770.03 +190.2%
DCF (Levered) 2,504.88 +310.6%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
4.64
Safe zone
Piotroski F-Score
7 / 9
Strong
MOAT Score
6 / 10
Developing
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • Revenue growth Medical - Healthcare Information Services: +14.2%
    +8.1% Q1'26: +3.7% (vs Q1'25)
  • EPS growth Medical - Healthcare Information Services: +43.1%
    +43.1% Q1'26: +7.4% (vs Q1'25)
  • FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +16.7% Q1'26: +70.6% (vs Q1'25)
  • EBIT margin Medical - Healthcare Information Services: +8.8%
    +15.6% Q1'26: +10.7% (vs Q1'25)
  • ROIC Medical - Healthcare Information Services: +5.2%
    +56.3% Q1'26: +35.2% (vs Q1'25)
  • Share dilution Medical - Healthcare Information Services: -0.1%
    +0.6% Q1'26: +0.5% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    0.28× Q1'26: 0.28× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.11) × ERP
WACC = 95% × Ke + 5% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 1,731.73 Current price: 610.00
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Sep 2015
actual
Sep 2016
actual
Sep 2017
actual
Sep 2018
actual
Sep 2019
actual
Sep 2020
actual
Sep 2021
actual
Sep 2022
actual
Sep 2023
actual
Sep 2024
actual
Sep 2025
actual
Sep 2026
1 Rev. Ana.
1 EPS Ana.
Sep 2027
1 Rev. Ana.
1 EPS Ana.
Sep 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
33.46B
est: 33.60B (-0.4%)
32.84B
est: 32.50B (+1.1%)
30.93B
est: 31.50B (-1.8%)
29.08B
est: 29.10B (-0.1%)
27.11B
est: 27.00B (+0.4%)
26.08B
est: 26.05B (+0.1%)
25.74B
est: 27.92B (-7.8%)
26.48B
est: 29.04B (-8.8%)
26.80B
est: 20.40B (+31.4%)
27.67B
est: 27.50B (+0.6%)
29.91B
est: 29.70B (+0.7%)
30.40B
30.40B – 30.40B
+2.4% YoY
32.20B
32.20B – 32.20B
+5.9% YoY
34.50B
34.50B – 34.50B
+7.1% YoY
EBITDA
5.86B
est: 3.82B (+53.4%)
6.57B
est: 3.69B (+77.9%)
4.55B
est: 3.58B (+27.0%)
3.93B
est: 3.31B (+18.8%)
4.06B
est: 3.07B (+32.4%)
3.22B
est: 2.96B (+8.9%)
2.45B
est: 3.17B (-22.9%)
1.44B
est: 3.30B (-56.3%)
2.91B
est: 2.32B (+25.5%)
5.17B
est: 3.55B (+45.3%)
6.02B
est: 3.84B (+56.9%)
3.93B
3.93B – 3.93B
+2.4% YoY
4.16B
4.16B – 4.16B
+5.9% YoY
4.46B
4.46B – 4.46B
+7.1% YoY
EBIT
4.45B
est: 1.64B (+171.5%)
5.20B
est: 1.59B (+227.9%)
2.75B
est: 1.54B (+79.0%)
2.10B
est: 1.42B (+47.6%)
2.56B
est: 1.32B (+94.4%)
1.22B
est: 1.27B (-4.2%)
992.86M
est: 1.36B (-27.1%)
-299.45M
est: 1.42B (-121.1%)
1.21B
est: 995.60M (+21.5%)
3.46B
est: 1.95B (+77.7%)
4.68B
est: 2.10B (+122.6%)
2.15B
2.15B – 2.15B
+2.4% YoY
2.28B
2.28B – 2.28B
+5.9% YoY
2.44B
2.44B – 2.44B
+7.1% YoY
Net Income
2.61B
est: 2.67B (-2.4%)
3.32B
est: 3.03B (+9.6%)
1.43B
est: 1.60B (-10.3%)
1.63B
est: 2.02B (-19.2%)
1.51B
est: 2.40B (-37.2%)
506.94M
est: 2.24B (-77.4%)
-1.16B
est: 2.76B (-142.1%)
-930.48M
est: 3.25B (-128.6%)
753.22M
est: 1.46B (-48.5%)
2.36B
est: 2.21B (+6.9%)
3.40B
est: 2.20B (+54.7%)
2.19B
2.19B – 2.19B
-0.5% YoY
2.49B
2.49B – 2.49B
+13.9% YoY
2.79B
2.79B – 2.79B
+12.0% YoY
SGA
22.46B
est: 20.23B (+11.0%)
20.57B
est: 19.57B (+5.1%)
19.28B
est: 18.97B (+1.7%)
17.71B
est: 17.52B (+1.1%)
15.58B
est: 16.26B (-4.1%)
14.77B
est: 15.68B (-5.8%)
15.63B
est: 16.81B (-7.0%)
16.40B
est: 17.48B (-6.2%)
16.66B
est: 12.28B (+35.6%)
16.50B
est: 16.99B (-2.9%)
19.28B
est: 18.35B (+5.1%)
18.78B
18.78B – 18.78B
+2.4% YoY
19.89B
19.89B – 19.89B
+5.9% YoY
21.31B
21.31B – 21.31B
+7.1% YoY
EPS
48.52
est: 48.60 (-0.2%)
59.54
est: 55.10 (+8.1%)
26.27
est: 29.10 (-9.7%)
29.85
est: 36.70 (-18.7%)
27.57
est: 43.70 (-36.9%)
9.28
est: 40.80 (-77.3%)
-21.28
est: 50.30 (-142.3%)
-16.99
est: 59.10 (-128.7%)
13.73
est: 26.60 (-48.4%)
43.04
est: 40.00 (+7.6%)
61.62
est: 39.80 (+54.8%)
39.60
39.60 – 39.60
-0.5% YoY
45.10
45.10 – 45.10
+13.9% YoY
50.50
50.50 – 50.50
+12.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 A+ 4/5 5/5 5/5 5/5 3/5 3/5 3/5
2026-05-11 A+ 4/5 5/5 5/5 5/5 3/5 3/5 3/5
2026-05-08 A+ 4/5 5/5 5/5 5/5 3/5 3/5 3/5
2026-05-07 A+ 4/5 5/5 5/5 5/5 3/5 3/5 3/5
2026-05-01 A 4/5 5/5 5/5 5/5 2/5 3/5 3/5
2026-04-30 A 4/5 5/5 5/5 5/5 2/5 3/5 3/5
2026-04-28 A 4/5 5/5 5/5 5/5 2/5 3/5 3/5
2026-04-27 A 4/5 5/5 5/5 5/5 2/5 3/5 3/5
2026-04-24 A 4/5 5/5 5/5 5/5 2/5 3/5 3/5
2026-04-23 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-22 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-21 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-20 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-17 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5
2026-04-16 A 4/5 5/5 4/5 5/5 2/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
5.59B
OE per share TTM
101.11
Owner's Yield
16.80%
Maintenance CapEx ratio
6.06%
Maint CapEx / Avg PPE
0.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
Total invested
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 6 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 WisdomTree Japan SmallCap Dividend Fund DFJ 0.03% 105.9K 0.58%
2 WisdomTree International Equity Fund DWM 0.01% 45.2K 0.48%
3 iShares Core TOPIX ETF 1475.T 0.00% 89.6K 0.05%
4 Dimensional - International Core Equity 2 ETF DFIC 0.00% 36.7K 0.22%
5 Dimensional World ex U.S. Core Equity 2 ETF DFAX 0.00% 12.4K 0.28%
6 Amundi Japan TOPIX II UCITS ETF EUR Dist JPNU.L 0.00% 143.14 0.45%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
3.95M
Shares Outstanding
55.49M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Giovanni Bertonha Senior Executive Officer Technology Division & System Architect Manager
Hiro Ichinokura MD & Director male
Hiroshi Izumi EVP, GM of Life, Ent, Sports,Tech. HQ, Cyber Risk Mgt Off., Dsgn Dept Comp. Prom. Off. & Dir. male
Hiroshi Matsumoto Senior MD & Director male
Kazuko Ohya Advisor female
Koichi Ishikawa MD, Director & GM of Smart Contents Department male
Satoshi Fujita Advisor male
Takahiro Taura Senior Executive Officer of Mobile Services Sales Division
Tomoo Shimizu Senior Executive Officer and Head of Finance, Accounting & Legal Affairs Headquarters
Toshihiro Maeta Chairman, CEO & President male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits